| 摘要 |
<p>Disclosed are novel substituted 3-aralkyl-imidazolines of structure (I), processes for their preparation, intermediates useful in their preparation, pharmaceutical compositions containing them and their use in therapy in particular as dopamine-β-hydroxylase inhibitors.</p> |
